Elvis Awuni

ORCID, self-asserted

ORCID 0000-0001-6719-7010

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

7 works in the graph, newest first.

Combined antibacterial effects of turmeric and cinnamon ethanolic extracts with ampicillin against resistant-microbial strains: in vitro and molecular docking approaches
2026Discover Applied SciencesJournalOpen access0 citations10.1007/s42452-026-08319-4
Unveiling nicotiflorin analogs with improved oral drug-like metrics as candidates for the development of dengue virus NS2B-NS3 protease inhibitors: An in silico study
2026Journal of Chemical ResearchJournalOpen accessFirst authorCorresponding0 citations10.1177/17475198261469655
An overview of drugging the bacterial cytoskeleton, rod, and divisome systems
2025SLAS DISCOVERYJournalOpen accessFirst authorCorresponding1 citations10.1016/j.slasd.2025.100261
Identification of lead small molecules for the design and development of potent severe acute respiratory syndrome coronavirus 2 main protease inhibitors
2025Journal of Chemical ResearchJournalOpen accessFirst authorCorresponding0 citations10.1177/17475198251326083
Evaluating the MreB-Binding Prospects of Proposed Antibacterial Peptides through Molecular Modeling and Simulations
2024Journal of Computational Biophysics and ChemistryJournalOpen accessFirst authorCorresponding1 citations10.1142/s2737416524500558
Proposing lead compounds for the development of SARS-CoV-2 receptor-binding inhibitors
2023Journal of Biomolecular Structure and DynamicsJournalFirst authorCorresponding1 citations10.1080/07391102.2023.2204505
Modeling the MreB-CbtA Interaction to Facilitate the Prediction and Design of Candidate Antibacterial Peptides
2022Frontiers in Molecular BiosciencesJournalOpen accessFirst authorCorresponding2 citations10.3389/fmolb.2021.814935